Approval · Notice of Compliance 29355 · 2022
COZAAR: Notice of Compliance 29355
Issued November 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29355
- Date
- November 1, 2022
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Plain Language Labelling (PLL) review of the labels for the 50 and 100 mg strengths due to a transfer in the drug product packaging and labelling site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COZAAR | Not yet assigned | — |
Medicinal ingredients
- LOSARTAN POTASSIUM 50 MG per TAB
- LOSARTAN POTASSIUM 100 MG per TAB